Resources Contact Us Home
Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE
 
 
Browse by Category: Main > Health & Medicine
Class Information
Number: 514/253.13
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Hetero ring is six-membered consisting of two nitrogens and four carbon atoms (e.g., pyridazines, etc.) > 1,4 diazines > Piperazines (i.e., fully hydrogenated 1,4-diazines) > Additional hetero ring attached directly or indirectly to the piperazine ring by nonionic bonding > The additional hetero ring is six-membered consisting of one nitrogen and five carbon atoms > Having -c(=x)-, wherein x is chalcogen, bonded directly to the additional six-membered nitrogen hetero ring
Description: Subject matter wherein the additional six-membered nitrogen hetero ring consisting of five ring carbons and one ring nitrogen has a -C(=X)- group, wherein X is chalcogen (i.e. oxygen, sulfur, selenium, or tellurium), bonded directly thereto.










Patents under this class:
1 2 3 4 5 6

Patent Number Title Of Patent Date Issued
7276509 Piperidine derivatives and their use as antagonists of tachykinins Oct. 2, 2007
7276500 Substituted amides, their preparation and use Oct. 2, 2007
7214714 20-hydroxyeicosatetraenoic acid production inhibitors May. 8, 2007
7196080 Phenylpyridinecarbonylpiperazinederivative Mar. 27, 2007
7176205 Bi-pyridinyl derivatives as NK-1 antagonists Feb. 13, 2007
7157463 Substituted piperidines/piperazines as melanocortin receptor agonists Jan. 2, 2007
7153824 Inhibitors of phosphodiesterases in infertility Dec. 26, 2006
7138396 17 .beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Nov. 21, 2006
7119092 Chemical compounds Oct. 10, 2006
7115607 Substituted piperazinyl amides and methods of use Oct. 3, 2006
7098212 Piperazine derivatives Aug. 29, 2006
7098213 CCR5 antagonists useful for treating AIDS Aug. 29, 2006
7060702 Chemical compounds Jun. 13, 2006
7008946 CCR5 antagonists useful for treating AIDS Mar. 7, 2006
6982256 Tolerance of 4-(4-(2-pyrrolylcarbonyl)-1-piperazinyl)-3-trifluoromethyl-be- nzoylguanidine in intravenous administration Jan. 3, 2006
6953774 Methods of inducing ovulation Oct. 11, 2005
6949539 Admantane derivatives Sep. 27, 2005
6936614 Piperidine-piperazine ligands for neurotransmitter receptors Aug. 30, 2005
6916817 Inhibitors of metalloproteinases Jul. 12, 2005
6903102 17.beta.-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases Jun. 7, 2005
6900211 CCR5 antagonists useful for treating aids May. 31, 2005
6846826 Phenoxypropanol connected with phenylpiperazine and phenoxyalkylamine terminal in its side chain Jan. 25, 2005
6809093 2-substituted heterocyclic compounds Oct. 26, 2004
6770650 Cyclic amine derivatives-CCR-3 receptor antagonists Aug. 3, 2004
6720325 CCR5 antagonists useful for treating aids Apr. 13, 2004
6713479 Piperidine-piperazine ligands for neurotransmitter receptors Mar. 30, 2004
6693099 Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance Feb. 17, 2004
6660739 Heterocyclic amides as inhibitors of factor Xa Dec. 9, 2003
6653313 1,4-dihydropyridine compounds as bradykinin antagonists Nov. 25, 2003
6642226 Substituted phenyl-piperidine methanone compounds Nov. 4, 2003
6638935 Heteroary1 derivatives and their use as medicaments Oct. 28, 2003
6635658 Amino-tetralin derivatives as muscarinic receptor antagonists Oct. 21, 2003
6630473 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives Oct. 7, 2003
6608060 Inhibitors of p38 Aug. 19, 2003
6596724 Oxadiazole and thiadiazole derivatives of dihydropyridine NPY antagonists Jul. 22, 2003
6596745 Method for treating fibrotic diseases with azolium chroman compounds Jul. 22, 2003
6521621 1-(1,2-disubstituted piperidinyl)-4-substituted piperazine derivatives Feb. 18, 2003
6492368 Benzamidine derivatives as factor XA inhibitors Dec. 10, 2002
6479483 4-phenyl-pyridine derivatives Nov. 12, 2002
6472397 Nitrogen-containing heterocyclic compounds having antiplatelet aggregation effect and medicinal use thereof Oct. 29, 2002
RE37886 1-(1,2-Disubstituted piperidinyl)-4-substituted piperazine derivatives Oct. 15, 2002
6458790 Substituted piperidines as melanocortin receptor agonists Oct. 1, 2002
6458793 Heterocyclic derivatives which inhibit factor Xa Oct. 1, 2002
6455528 Piperazine compounds and medicinal use thereof Sep. 24, 2002
6451803 N-acyl and n-aroyl aralkyl amides useful in treating seritonergic disorders Sep. 17, 2002
6432956 Method for treatment of sleep apneas Aug. 13, 2002
6432960 Squarate derivatives of dihydropyridine NPY antagonists Aug. 13, 2002
6423710 Cyclic AMP-specific phosphodiesterase inhibitors Jul. 23, 2002
6391881 Thiourea derivatives of dihydropyridine NPY antagonists May. 21, 2002
6358980 Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors Mar. 19, 2002

1 2 3 4 5 6










 
 
  Recently Added Patents
Smartphone
Transferring a document
Method and apparatus for using virtual machine technology for managing parallel communicating applications
Vertical axis wind turbines
Electronic device with a screen
Process cartridge and electrophotographic image forming apparatus
Quantitative sleep analysis system and method
  Randomly Featured Patents
Data transmitter device
System for scheduling readahead operations if new request is within a proximity of N last read requests wherein N is dependent on independent activities
Inbox management
Cable harness breakout assembly method
Toner and developer compositions with charge enhancing additives
Generator adaptor
Automated banking machine with noncontact reading of card data
Method for supplying aromas, apparatus therefore and facilities provided with same
Hand operated cutting tool
Vehicle display system